Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Neostem (NY: NBS)
0.5700 USD  -0.0125 (-2.15%)
Official Closing Price  /  Updated: 4:15 PM EDT, May 23, 2013  /  Add to My Watchlist      
View: Quote News Research
Press releases about Neostem
 
< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
NeoStem Announces Geographic Expansion of Intellectual Property Coverage of Cardiovascular Asset AMR-001
May 16, 2013
from GlobeNewswire News Releases
NeoStem to Present at Multiple Conferences in May
May 14, 2013
from GlobeNewswire News Releases
NeoStem's Subsidiary, Progenitor Cell Therapy, to Provide Autologous and Allogeneic Cellular Therapy Services to MedStar Georgetown University Hospital
May 13, 2013
from GlobeNewswire News Releases
NeoStem Clarification: No New Securities Being Issued
May 09, 2013
from GlobeNewswire News Releases
NeoStem CEO's Letter to Shareholders
May 09, 2013
from GlobeNewswire News Releases
NeoStem Announces Closing of Public Offering of Common Stock
May 03, 2013
from GlobeNewswire News Releases
Free Research Reports on DDD, ESRX, NBS and TTHI Issued by the Bedford Report
May 01, 2013
Note to Editors: The Following Is an Investment Opinion Being Issued by the EQUITY NEWS CIRCUIT Read More
from Marketwired News Releases
NeoStem Announces Partial Exercise of Underwriters' Over-Allotment Option
April 30, 2013
from GlobeNewswire News Releases
NeoStem Announces Pricing of Public Offering of Common Stock
April 29, 2013
from GlobeNewswire News Releases
NeoStem Announces Proposed Public Offering of Common Stock
April 29, 2013
from GlobeNewswire News Releases
NeoStem's Subsidiary, Progenitor Cell Therapy, Enters Into a Services Agreement With Sentien Biotechnologies, Inc.
April 29, 2013
from GlobeNewswire News Releases
NeoStem to Present at Multiple Conferences in April
April 01, 2013
from GlobeNewswire News Releases
NeoStem Awarded Second Year of NIAID Research Grant for the Development of VSEL Technology for Radiation Exposure
March 28, 2013
from GlobeNewswire News Releases
NeoStem CEO's Letter to Shareholders
March 19, 2013
from GlobeNewswire News Releases
NeoStem's Subsidiary, Progenitor Cell Therapy, Launches Web-Based Service for Real-Time Cell Therapy Product Tracking
March 18, 2013
from GlobeNewswire News Releases
NeoStem Announces Intellectual Property Expansion in Cardiovascular Disease
March 13, 2013
from GlobeNewswire News Releases
NeoStem Announces 2012 Year End Financial Results and Business Update
March 11, 2013
Revenues Increased by 43% Read More
from GlobeNewswire News Releases
NeoStem Reports Second Data Safety Monitoring Board Review: Continue With PreSERVE AMI Phase 2 Trial as Planned
March 07, 2013
from GlobeNewswire News Releases
NeoStem Appoints Stephen W. Potter to Board of Directors
February 11, 2013
from GlobeNewswire News Releases
NeoStem to Present at Multiple Conferences in February
February 07, 2013
from GlobeNewswire News Releases
NeoStem's Vice President of Clinical Development and Regulatory Affairs to Present at Two Venues This Week
February 04, 2013
from GlobeNewswire News Releases
Free Research Report on Maxwell Technologies, Inc., Myrexis, Inc., NeoStem, Inc., Navigant Consulting Co. and National Grid Plc
January 31, 2013
from PR Newswire
Major Revenue Losses From Patent Expirations Forces Big Pharma Companies to Look to the Biotech Industry for Replacements
January 23, 2013
Five Star Equities Provides Stock Research on Discovery Laboratories and NeoStem Read More
from Marketwired News Releases
NeoStem Announces Further Expansion of Intellectual Property Coverage
January 22, 2013
from GlobeNewswire News Releases
NeoStem's Subsidiary, Progenitor Cell Therapy, Enters Into a Cell Therapy Manufacturing Services Agreement With Adaptimmune
January 16, 2013
PCT to Provide Cell Product Development and Manufacturing for Adaptimmune's Clinical Trials Read More
from GlobeNewswire News Releases
NeoStem Announces Receipt of Hellman Research Award by Academic Collaborator for VSEL(TM) Research
January 15, 2013
from GlobeNewswire News Releases
NeoStem Announces Research Supporting VSEL(TM) Technology Presented at the American Society of Hematology Annual Meeting
January 09, 2013
from GlobeNewswire News Releases
NeoStem's Subsidiary, Progenitor Cell Therapy, and Hackensack University Medical Center Enter Into a Cell Processing and Storage Services Agreement
January 07, 2013
from GlobeNewswire News Releases
NeoStem to Present at Multiple Conferences in January
January 02, 2013
from GlobeNewswire News Releases
Improving Trend in FDA First Cycle Review Approvals a Major Factor for Biotech Industry's Success in 2012
December 05, 2012
Five Star Equities Provides Stock Research on Celldex Therapeutics and Neostem Read More
from Marketwired News Releases
< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here